DGS Capital Management’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $338K | Buy |
15,340
+1,713
| +13% | +$37.8K | 0.08% | 206 |
|
|
2024
Q3 | $246K | Buy |
13,627
+872
| +7% | +$15.7K | 0.07% | 245 |
|
|
2024
Q2 | $207K | Buy |
12,755
+1,175
| +10% | +$19.1K | 0.06% | 260 |
|
|
2024
Q1 | $163K | Buy |
11,580
+191
| +2% | +$2.7K | 0.05% | 274 |
|
|
2023
Q4 | $119K | Buy |
+11,389
| New | +$119K | 0.05% | 238 |
|
|
2023
Q2 | – | Sell |
-14,047
| Closed | -$124K | – | 258 |
|
|
2023
Q1 | $124K | Sell |
14,047
-1,204
| -8% | -$10.7K | 0.07% | 204 |
|
|
2022
Q4 | $139K | Buy |
15,251
+4,327
| +40% | +$39.5K | 0.09% | 204 |
|
|
2022
Q3 | $88.2K | Buy |
+10,924
| New | +$88.2K | 0.06% | 193 |
|
|
2022
Q2 | – | Sell |
-15,611
| Closed | -$147K | – | 221 |
|
|
2022
Q1 | $147K | Buy |
+15,611
| New | +$147K | 0.09% | 179 |
|